Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format pdf download PDF
side by side viewer icon HTML

Abstract

Purpose

This study aimed to evaluate the Pharmacovigilance (PV) and severity of hypersensitivity reactions induced by non-ionic Iodinated Contrast Media (ICM) in the radiology diagnosis reported to the United States Food and Drug Administration Adverse Event Reporting System (FAERS).

Methods

We retrospectively reviewed the reports of ICM-induced hypersensitivity reactions submitted to the FAERS database between January 2015 and January 2023 and conducted a disproportionality analysis. The seven most common non-ionic ICM, including iohexol, iopamidol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol, were chiefly analyzed. Our primary endpoint was the PV of non-ionic ICM-induced total hypersensitivity events. STATA 17.0 MP was used for statistical analysis.

Results

In total, 35357 reports of adverse reaction events in radiology diagnosis were retrieved from the FAERS database. Among them, 6181 reports were on hypersensitivity reaction events (mean age: 57.1 ± 17.8 years). The hypersensitivity reaction-related PV signal was detected for iohexol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol, but not for iopamidol. The proportion of iomeprol-induced hypersensitivity reactions and the probability of ioversol-induced severe hypersensitivity reactions have been found to be significantly increased.

Conclusion

The probability and severity of hypersensitivity reaction events in non-ionic ICM are different. Iohexol, ioversol, iopromide, iomeprol, iobitridol, and iodixanol have higher risks compared to iopamidol. In addition, the constituent ratio of hypersensitivity reactions induced by iomeprol is significantly increased, and the associated probability induced by ioversol is significantly increased.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056306358240607115422
2024-01-01
2025-07-16

  • From This Site

    /content/journals/cmir/10.2174/0115734056306358240607115422
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. BoehmI. NairzK. MorelliJ. Silva Hasembank KellerP. HeverhagenJ.T. General anaesthesia for patients with a history of a contrast medium-induced anaphylaxis: a useful prophylaxis?Br. J. Radiol.20179010792016064710.1259/bjr.2016064728876979
     [Google Scholar]
  2. JangE.B. SuhC.H. KimP.H. KimA.Y. DoK.H. LeeJ.H. GwonD.I. JungA.Y. LeeC.W. Incidence and severity of nonionic low-osmolar iodinated contrast medium-related adverse drug reactions in the Republic of Korea: Comparison by generic.Medicine202310219e3371710.1097/MD.000000000003371737171360
     [Google Scholar]
  3. FukushimaY. Taketomi-TakahashiA. SutoT. HirasawaH. TsushimaY. Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.Eur. J. Radiol.202316411088010.1016/j.ejrad.2023.11088037187078
     [Google Scholar]
  4. WuY.W. LeowK.S. ZhuY. TanC.H. Prevention and management of adverse reactions induced by iodinated contrast media.Ann. Acad. Med. Singap.201645415716410.47102/annals‑acadmedsg.V45N4p15727292007
     [Google Scholar]
  5. BrockowK. Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism?Immunol. Allergy Clin. North Am.200929345346810.1016/j.iac.2009.04.00119563991
     [Google Scholar]
  6. CardonaV. AnsoteguiI.J. EbisawaM. El-GamalY. Fernandez RivasM. FinemanS. GellerM. Gonzalez-EstradaA. GreenbergerP.A. Sanchez BorgesM. SennaG. SheikhA. TannoL.K. ThongB.Y. TurnerP.J. WormM. World allergy organization anaphylaxis guidance 2020.World Allergy Organ. J.2020131010047210.1016/j.waojou.2020.10047233204386
     [Google Scholar]
  7. Rosado IngelmoA. Doña DiazI. Cabañas MorenoR. Moya QuesadaM. García-AvilésC. García NuñezI. Martínez TadeoJ. Mielgo BallesterosR. Ortega-RodríguezN. Padial VilchezM. Sánchez-MorillasL. Vila AlbeldaC. Moreno RodillaE. Torres JaénM. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media.J. Investig. Allergol. Clin. Immunol.201626314415510.18176/jiaci.005827326981
     [Google Scholar]
  8. BöhmI. HeverhagenJ.T. KloseK.J. Classification of acute and delayed contrast media‐induced reactions: Proposal of a three‐step system.Contrast Media Mol. Imaging20127653754110.1002/cmmi.147522991320
     [Google Scholar]
  9. TannoL.K. TorresM.J. CastellsM. DemolyP. What can we learn in drug allergy management from World Health Organization’s international classifications?Allergy201873598799210.1111/all.1333529105793
     [Google Scholar]
  10. BrockowK. ChristiansenC. KannyG. ClémentO. BarbaudA. BircherA. DeWachterP. GuéantJ.L. Rodriguez GuéantR.M. Mouton-FaivreC. RingJ. RomanoA. Sainte-LaudyJ. DemolyP. PichlerW.J. Management of hypersensitivity reactions to iodinated contrast media.Allergy200560215015810.1111/j.1398‑9995.2005.00745.x15647034
     [Google Scholar]
  11. TorresM.J. TrautmannA. BöhmI. SchererK. BarbaudA. BavbekS. BonadonnaP. CernadasJ.R. ChiriacA.M. GaetaF. Gimenez-ArnauA.M. KangH.R. MorenoE. BrockowK. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.Allergy20217651325133910.1111/all.1465633170954
     [Google Scholar]
  12. BrockowK. Medical algorithm: Diagnosis and treatment of radiocontrast media hypersensitivity.Allergy20207551278128010.1111/all.1414731823375
     [Google Scholar]
  13. BrockowK. Ardern-JonesM.R. MockenhauptM. AbererW. BarbaudA. CaubetJ.C. SpiewakR. TorresM.J. MortzC.G. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.Allergy2019741142710.1111/all.1356230028512
     [Google Scholar]
  14. BrockowK. RomanoA. AbererW. BircherA.J. BarbaudA. BonadonnaP. FariaE. KannyG. LerchM. PichlerW.J. RingJ. Rodrigues CernadasJ. TomazE. DemolyP. ChristiansenC. Skin testing in patients with hypersensitivity reactions to iodinated contrast media a European multicenter study.Allergy200964223424110.1111/j.1398‑9995.2008.01832.x19178403
     [Google Scholar]
  15. KimS.R. LeeJ.H. ParkK.H. ParkH.J. ParkJ.W. Varied incidence of immediate adverse reactions to low‐osmolar non‐ionic iodide radiocontrast media used in computed tomography.Clin. Exp. Allergy201747110611210.1111/cea.1280327648932
     [Google Scholar]
  16. MeucciE. RadiceA. FassioF. SibilioM. IornoM.L.C. TestiS. SeverinoM. MacchiaD. Diagnostic approach to hypersensitivity reactions to iodinated contrast media: A single-center experience on 98 patients.Eur. Ann. Allergy Clin. Immunol.202052522022910.23822/EurAnnACI.1764‑1489.12931920060
     [Google Scholar]
  17. DhodapkarM.M. ShiX. RamachandranR. ChenE.M. WallachJ.D. RossJ.S. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: Cross sectional study.BMJ2022379e07175210.1136/bmj‑2022‑07175236198428
     [Google Scholar]
  18. DuggiralaH.J. TonningJ.M. SmithE. BrightR.A. BakerJ.D. BallR. BellC. Bright-PonteS.J. BotsisT. BouriK. BoyerM. BurkhartK. Steven CondreyG. ChenJ.J. ChirtelS. FiliceR.W. FrancisH. JiangH. LevineJ. MartinD. OladipoT. O’NeillR. PalmerL.A.M. ParedesA. RochesterG. SholtesD. SzarfmanA. WongH.L. XuZ. Kass-HoutT. Use of data mining at the food and drug administration.J. Am. Med. Inform. Assoc.201623242843410.1093/jamia/ocv06326209436
     [Google Scholar]
  19. AnJ. JungH. KwonO.Y. KangY. LeeJ.H. WonH.K. SongW.J. KwonH.S. ChoY.S. MoonH.B. KimT.B. Differences in adverse reactions among iodinated contrast media: Analysis of the KAERS database.J. Allergy Clin. Immunol. Pract.2019772205221110.1016/j.jaip.2019.02.03530877072
     [Google Scholar]
  20. LinX. YangJ. WengL. LinW. Differences in hypersensitivity reactions to iodinated contrast media: Analysis of the US Food and Drug administration adverse event reporting system database.J. Allergy Clin. Immunol. Pract.202311514941502.e610.1016/j.jaip.2023.01.02736736956
     [Google Scholar]
  21. EvansS.J.W. WallerP.C. DavisS. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.Pharmacoepidemiol. Drug Saf.200110648348610.1002/pds.67711828828
     [Google Scholar]
  22. NorénG.N. HopstadiusJ. BateA. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery.Stat. Methods Med. Res.2013221576910.1177/096228021140360421705438
     [Google Scholar]
  23. van PuijenbroekE.P. BateA. LeufkensH.G.M. LindquistM. OrreR. EgbertsA.C.G. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.Pharmacoepidemiol. Drug Saf.200211131010.1002/pds.66811998548
     [Google Scholar]
  24. KhaleelM.A. KhanA.H. GhadziS.M.S. AdnanA.S. AbdallahQ.M. A standardized dataset of a spontaneous adverse event reporting system.Healthcare202210342010.3390/healthcare1003042035326898
     [Google Scholar]
  25. LiuY. ZhangH. JiangY. WenZ. BaoE. HuangJ. WangC. ChenC. WangJ. YangX. Cardiovascular adverse events associated with new-generation androgen receptor pathway inhibitors (ARPI) for prostate cancer: A disproportionality analysis based on the FDA adverse event reporting system (FAERS).Clin. Genitourin. Cancer2023215594601.e210.1016/j.clgc.2023.07.00337482524
     [Google Scholar]
  26. De MartinisM. SirufoM.M. SuppaM. Di SilvestreD. GinaldiL. Sex and gender aspects for patient stratification in allergy prevention and treatment.Int. J. Mol. Sci.2020214153510.3390/ijms2104153532102344
     [Google Scholar]
  27. ChaM.J. KangD.Y. LeeW. YoonS.H. ChoiY.H. ByunJ.S. LeeJ. KimY.H. ChooK.S. ChoB.S. JeonK.N. JungJ.W. KangH.R. Hypersensitivity reactions to iodinated contrast media: A multicenter study of 196 081 patients.Radiology2019293111712410.1148/radiol.201919048531478801
     [Google Scholar]
  28. WidmannG. BaleR. UlmerH. PutzerD. SchullianP. WiedermannF.J. LedererW. Systemic hypotension following intravenous administration of nonionic contrast medium during computed tomography: Iopromide versus iodixanol.Anesth. Analg.2018126376977510.1213/ANE.000000000000234628806208
     [Google Scholar]
  29. SoriaA. AmslerE. BernierC. MilpiedB. TétartF. MoriceC. DezoteuxF. Ferrier-Le BouedecM.C. BarbaudA. Staumont-SalléD. AssierH. DRESS and AGEP reactions to iodinated contrast media: A french case series.J. Allergy Clin. Immunol. Pract.2021983041305010.1016/j.jaip.2021.02.06033757916
     [Google Scholar]
  30. TanC.M. ZipurskyJ.S. Acute generalized exanthematous pustulosis caused by an intravenous radiocontrast medium.CMAJ202019238E109710.1503/cmaj.20036432958574
     [Google Scholar]
  31. SchwartzL.B. MetcalfeD.D. MillerJ.S. EarlH. SullivanT. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.N. Engl. J. Med.1987316261622162610.1056/NEJM1987062531626033295549
     [Google Scholar]
  32. BrockowK. RingJ. Anaphylaxis to radiographic contrast media.Curr. Opin. Allergy Clin. Immunol.201111432633110.1097/ACI.0b013e32834877c321659863
     [Google Scholar]
  33. RingJ. ArroyaveC.M. FrizlerM.J. TanE.M. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and independent release reaction and changes in ultrastructure of human blood cells.Clin. Exp. Immunol.197832110511878780
     [Google Scholar]
  34. SzebeniJ. Hypersensitivity reactions to radiocontrast media: The role of complement activation.Curr. Allergy Asthma Rep.200441253010.1007/s11882‑004‑0038‑914680617
     [Google Scholar]
  35. ChristiansenC. X-ray contrast media : An overview.Toxicology2005209218518710.1016/j.tox.2004.12.02015767033
     [Google Scholar]
  36. GómezE. Blanca-LopezN. SalasM. CantoG. CampoP. TorresM.J. MayorgaC. BlancaM. Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms.Ann. Allergy Asthma Immunol.2013110426727310.1016/j.anai.2013.01.00323535091
     [Google Scholar]
  37. BlancaM. TorresM.J. LeyvaL. MayorgaC. PosadasS. GonzalezL. FernándezJ. JuarezC. SantamariaL.F. Expression of the skin‐homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneousallergic drug reactions.Allergy20005511998100410.1034/j.1398‑9995.2000.00628.x11097307
     [Google Scholar]
  38. MayorgaC. PenaR.R. Blanca-LópezN. LópezS. MartinE. TorresM.J. Monitoring the acute phase response in non-immediate allergic drug reactions.Curr. Opin. Allergy Clin. Immunol.20066424925710.1097/01.all.0000235897.72429.4a16825864
     [Google Scholar]
/content/journals/cmir/10.2174/0115734056306358240607115422
Loading
Hypersensitivity Reactions Induced by Iodinated Contrast Media in Radiological Diagnosis: A Disproportionality Analysis Based on the FAERS Database
Curr. Med. Imaging 20, e15734056306358 (2024); https://doi.org/10.2174/0115734056306358240607115422
/content/journals/cmir/10.2174/0115734056306358240607115422
/content/journals/cmir/10.2174/0115734056306358240607115422
Loading

Data & Media loading...

Supplements

Supplementary material is available on the Publisher’s website.

file format download Download

  • Article Type:     Research Article
Keyword(s): Disproportionality analysis; FAERS; Food and drug administration adverse event reporting system; Hypersensitivity reactions; Iodinated contrast media; Radiology

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test